Abe Rei, Beckett Joel, Abe Ryuzo, Nixon Alexander, Rochier Adrienne, Yamashita Norio, Sumpio Bauer
Section of Vascular Surgery, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut.
Int J Angiol. 2012 Jun;21(2):69-76. doi: 10.1055/s-0032-1315630.
We hypothesized that polyphenols contained in olive oil play a role in reducing the risk of atherosclerosis. The aim of this study was to determine if the polyphenols in olive oil, oleuropein (Ole), hydroxytyrosol (HT), and tyrosol (Tyr) could inhibit smooth muscle cell (SMC) proliferation through its influence on cell cycle regulation. Bovine vascular SMC were cultured in the presence of Ole, HT, or Tyr at concentration of 1, 10, or 100 μmol/L. On days 1, 3, and 5, numbers of cells were counted. Cell cycle analysis was performed by flow cytometry on day 1 after SMC were stained with propidium iodide. Cell populations grown in the presence of Ole or HT at 100 μmol/L concentration were significantly inhibited after 5 days of exposure. Tyr had a similar tendency but it did not attain significance. Cell cycle analysis revealed that 66% of cells were in G1 phase in Ole group, compared with 48% in control group. To examine the cell cycle block between G1 and S phases, we performed Western blotting and found that ERK1/2 activation was inhibited by Ole or HT. We conclude that olive oil polyphenols could inhibit SMC proliferation through a cell cycle block between G1 and S phases which may be regulated by ERK1/2. These results demonstrate a mechanism by which olive oil consumption may be atheroprotective by inhibiting SMC proliferation.
我们推测橄榄油中含有的多酚在降低动脉粥样硬化风险方面发挥作用。本研究的目的是确定橄榄油中的多酚,即橄榄苦苷(Ole)、羟基酪醇(HT)和酪醇(Tyr)是否能通过影响细胞周期调控来抑制平滑肌细胞(SMC)增殖。将牛血管平滑肌细胞在浓度为1、10或100μmol/L的Ole、HT或Tyr存在下培养。在第1、3和5天,对细胞数量进行计数。在平滑肌细胞用碘化丙啶染色后第1天,通过流式细胞术进行细胞周期分析。在100μmol/L浓度的Ole或HT存在下生长的细胞群体在暴露5天后受到显著抑制。Tyr有类似趋势,但未达到显著水平。细胞周期分析显示,Ole组66%的细胞处于G1期,而对照组为48%。为了检查G1期和S期之间的细胞周期阻滞,我们进行了蛋白质免疫印迹分析,发现Ole或HT抑制了ERK1/2的激活。我们得出结论,橄榄油多酚可通过G1期和S期之间的细胞周期阻滞来抑制SMC增殖,这可能由ERK1/2调节。这些结果证明了食用橄榄油可能通过抑制SMC增殖而具有抗动脉粥样硬化作用的一种机制。